What Agio does

Agio Pharmaceuticals Limited is an India-based, privately-held pharmaceutical manufacturer founded in 1991 and headquartered in Mumbai. The company develops, manufactures, and markets a broad portfolio of over 365 formulations spanning more than 20 therapeutic segments, organized into two lines: Human Healthcare (ethical medicines, OTC products, and herbal formulations) and Animal Healthcare (veterinary medicines). Manufacturing and R&D are co-located at a WHO GMP-approved facility in Bhosari, Pune, where the company operates a DSIR-approved (Department of Scientific and Industrial Research, Government of India) R&D laboratory. Technology is centered on pharmaceutical formulation development rather than novel molecule discovery; the R&D function is positioned as a source of differentiated formulations and incremental product innovation.

The company generates revenue through one-time product sales across both domestic Indian markets and a 40-plus-country export footprint spanning Russia, CIS countries, Sri Lanka, Philippines, Netherlands, Latin America, and Africa. Its go-to-market is a structured enterprise field sales force organized by specialty, calling on doctors, hospitals, and polyclinics, combined with a multi-tier domestic distribution channel of carrying-and-forwarding agents (C&A), stockists, and retailers concentrated in Western India. International markets are served through regional distributors, business development partners, and local organization alliances, supplemented by strategic partnerships with multinational organizations for licensing and co-development. The business holds an extensive stack of country-specific regulatory approvals — including WHO GMP, PIC/S, ISO 9001:2015, and FDA/GMP clearances in the Philippines, Russia, Kenya, Nigeria, Ghana, Rwanda, Ivory Coast, Uganda, Malawi, Yemen, Cambodia, Uzbekistan, Azerbaijan, and Moldova — that materially lower the regulatory barrier to entry across emerging markets and constitute a core asset of the franchise.

Name

Agio

Legal name

AGIO Pharmaceuticals Limited

Website

https://agio-pharma.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Agio Pharmaceuticals Limited is a privately-held Indian pharmaceutical manufacturer producing 365-plus formulations across 20-plus therapeutic segments in human and animal healthcare, exporting to 40-plus countries from a WHO GMP-approved facility in Pune.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

akta.pro secondary industries

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Generic formulations
• Veterinary medicines
• OTC products
• Herbal formulations

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Manufacturing and Marketing: Agio Pharmaceuticals develops, manufactures and markets a broad range of pharmaceutical products globally. The company offers ethical & OTC medicines, herbal formulations, and veterinary products. Revenue is generated through product sales across domestic and international markets with presence in over 40 countries.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Agio Pharmaceuticals develops, manufactures, and markets a diversified portfolio of over 365 pharmaceutical formulations across more than 20 therapeutic segments, spanning ethical medicines, OTC products, herbal formulations, and veterinary medicines. Products are manufactured in WHO GMP-approved facilities and distributed across more than 40 countries through a structured sales force and distribution network.

Product overview

Agio Pharmaceuticals operates as a pharmaceutical manufacturer offering a unified portfolio of human healthcare and veterinary products. The core offering consists of over 365 pharmaceutical formulations across more than 20 therapeutic segments, encompassing ethical medicines, OTC products, and herbal formulations. The product portfolio is divided into Human Healthcare (ethical and OTC medicines, herbal formulations) and Animal Healthcare (veterinary products) categories, with products manufactured in WHO GMP-approved facilities and distributed across over 40 countries globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Human Healthcare Products Pharmaceutical formulations including ethical medicines and over-the-counter (OTC) products for human health, covering more than 365 formulations across over 20 therapeutic segments. Targeted at doctors, hospitals, polyclinics, and retail pharmacies in India and 40+ international markets.
• Veterinary Products Animal healthcare pharmaceutical formulations and veterinary medicines offered as part of Agio's diversified portfolio targeting animal health markets alongside human healthcare products.
• Herbal Formulations Herbal and botanical-based pharmaceutical formulations offered within Agio's product portfolio to provide natural and traditional healthcare alternatives to patients.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Local OrganizationsminorStrategic or Co-development PartnerAgio partners with local organizations in various markets to deliver affordable and high-quality healthcare solutions. These partnerships help the company understand newer geographies and maintain customer-oriented approach.
• Multinational OrganizationscoreStrategic or Co-development PartnerAgio partners with multinational organizations for business development, licensing and partnerships. The company aims to constantly innovate and deliver affordable healthcare solutions through these strategic alliances.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Indoco Remedies: Mumbai-headquartered pharmaceutical manufacturer with a broad formulation portfolio and strong emerging-market export presence, directly comparable to Agio's manufacturing-plus-export motion.
• Ajanta Pharma: Indian branded-generic specialist exporting formulations to Africa, Asia and CIS markets, overlapping strongly with Agio's emerging-market export focus.
• Blue Cross Laboratories: Privately held Maharashtra-based pharma manufacturer of branded formulations for domestic and export markets, a close structural and geographic peer to Agio.
• FDC Limited: Mumbai-based mid-size Indian pharma company manufacturing branded formulations and OTC products for domestic and export markets, closely matching Agio's model and geography.
• Themis Medicare: Mumbai-based mid-size pharma manufacturer with human formulations and export operations, comparable in scale and model to Agio.

Broad incumbents

• Mankind Pharma: Indian pharma company spanning human and veterinary/OTC portfolios, sharing Agio's combined human-and-animal-health category focus at larger scale.
• Wockhardt: Larger Indian pharma manufacturer with global formulation and export operations; overlaps in category but with wider regulated-market reach than Agio.
• Zydus Lifesciences: Major diversified Indian pharma manufacturer with human and animal health and broad export operations; a scaled incumbent in the same overall category as Agio.
• Alembic Pharmaceuticals: Established Indian pharma company with formulations and API businesses across regulated and emerging markets; larger and more diversified than Agio but competing in the same category.

Emerging players

• Vetoquinol India: Veterinary pharmaceutical player relevant to Agio's animal-healthcare product line, overlapping on the veterinary segment of the portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/agio-pharmaceuticals-limited

Compliance20 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agio